Detection of respiratory viruses how, when, where and why?;Nachweis von Atemwegsviren Wie, warum, wann und wo?

Pneumologie

Volumn 63, Issue 1, 2009, Pages 14-22

  Rohde, G ^a   Drosten, C ^b   Borg, I ^a   Hauptmeier, B ^a   Ringshausen, F ^a   Schultze Werninghaus, G ^a   Uberla K ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; VIRUS ANTIGEN;

ADENOVIRUS; ASTHMA; BOCAVIRUS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONAVIRUS; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INFLUENZA VIRUS C; METAPNEUMOVIRUS; NONHUMAN; OUTPATIENT; PARAINFLUENZA VIRUS; POLYOMA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RHINOVIRUS; VIRUS CULTURE; VIRUS DETECTION; DIFFERENTIAL DIAGNOSIS; RECURRENT DISEASE; RESPIRATORY TRACT INFECTION; VIROLOGY; VIRUS ACTIVATION; VIRUS INFECTION;

DIAGNOSIS, DIFFERENTIAL; HUMANS; RECURRENCE; RESPIRATORY TRACT INFECTIONS; VIRUS ACTIVATION; VIRUS DISEASES;

EID: 65649090144     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-2008-1038292     Document Type: Review

References (94)

1. Modrow S, Falke D, Truyen U. Labormethoden zum Nachweis von Virusinfektionen. Molekulare Virologie. 2. ed. Heidelberg Berlin: Spektrum Akademischer Verlag GmbH, 2003: 114-129
2. Marshall DJ, Reisdorf E, Harms G et al. Evaluation of a Multiplexed PCR Assay for Detection of Respiratory Viral Pathogens in a Public Health Laboratory Setting. J Clin Microbiol 2007; 45: 3875-3882
3. Borg I, Rohde G, Loeseke S et al. Evaluation of a quantitative real-time PCR for the detection of RSV in pulmonary diseases. Eur Respir J 2003; 21: 944-951
4. Ieven M. Currently used nucleic acid amplification tests for the de? tection of viruses and atypicals in acute respiratory infections. J Clin Virol 2007; 40: 259-276
5. Stang A, Korn K, Wildner O et al. Characterization of Virus Isolates by Particle?Associated Nucleic Acid PCR. J Clin Microbiol 2005; 43: 716- 720
6. Ambrose HE, Clewley JP. Virus discovery by sequence independent ge nome amplification. Rev Med Virol 2006; 16: 365-383
7. Janeway CA Jr, Travers P, Walport M et al. D. Structure of the antibody molecule and the immunoglobulin genes. In: Janeway Jr. CA (ed). Immunobiology: the immune system in health and disease. 4. ed. Lon? don/New York: Elsevier Science Ltd/Garland Publishing, 1999: 79- 113
8. Xiang X, Qiu D, Chan KP et al. Comparison of three methods for respiratory virus detection between induced sputum and nasopharyngeal aspirate specimens in acute asthma. J Virol Methods 2002; 101: 127- 133
9. Beckham JD, Cadena A, Lin J et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect 2005; 50: 322-330
10. Monto AS, Ullman BM. Acute respiratory illness in an American community. The Tecumseh study. JAMA 1974; 227: 164-169
11. Macfarlane J, Holmes W, Gard P et al. Prospective study of the inci? dence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001; 56: 109-114
12. Meza RA, BridgesWebb C, Sayer GPet al. The management of acute bronchitis in general practice: results from the Australian Morbidity and Treatment Survey, 1990-1991. Aust Fam Physician 1994; 23: 1550-1553
13. Rohde G, Wiethege A, Borg I et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization -a case- control study. Thorax 2003; 58: 37-42
14. Forster J, Ihorst G, Rieger CH et al. Prospective population based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study). Eur J Pediatr 2004; 163: 709-716
15. Hoek L van der, Sure K, Ihorst G et al. Croup is associated with the novel coronavirus NL63. PLoS Med 2005 Aug ; 2 (8): e240
16. Yap FH, Ho PL, Lam KF et al. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol 2004; 73: 617-623
17. Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest 2000; 117: 380S-385S (Pubitemid 30314471)
18. Smith CB, Golden CA, Kanner RE et al. Association of viral and Myco plasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis 1980; 121: 225-232
19. Gump DW, Phillips CA, Forsyth BR et al. Role of infection in chronic bronchitis. Am Rev Respir Dis 1976; 113: 465-474
20. Buscho RO, Saxtan D, Shultz PS et al. Infections with viruses and Myco plasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis 1978; 137: 377-383
21. Seemungal T, Harper?Owen R, Bhowmik A et al. Respiratory Viruses, Symptoms, and Inflammatory Markers in Acute Exacerbations and Stable Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2001; 164: 1618-1623
22. Hutchinson AF, Ghimire AK, Thompson MA et al. A community based, time matched, case control study of respiratory viruses and exacer bations of COPD. Respir Med 2007; 101: 2472-2481
23. Rohde G, Borg I, Arinir U et al. Relevance of human metapneumovirus in exacerbations of COPD. Respir Res 2005; 6:150 doi : 0.1186/1465- 9921-6-150
24. Hamelin ME, Cote S, Laforge J et al. Human metapneumovirus infection in adults with community?acquired pneumonia and exacerbation of chronic obstructive pulmonary disease. Clin Infect Dis 2005; 41: 498-502
25. Martinello RA, Esper F, Weibel C et al. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J Infect 2006; 53: 248-254
26. Wilkinson TM, Donaldson GC, Johnston SL et al. Respiratory Syncytial Virus, Airway Inflammation and FEV1 Decline in Patients with COPD. Am J Respir Crit Care Med 2006; 173: 871-876
27. Matsuse T, Hayashi S, Kuwano K et al. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992; 146: 177-184
28. Retamales I, Elliott WM, Meshi B et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001; 164: 469-473
29. McManus TE, Marley AM, Baxter N et al. Acute and latent adenovirus in COPD. Respir Med 2007; 101: 2084-2090
30. Papadopoulos NG, Xepapadaki P, Mallia P et al. Mechanisms of virus induced asthma exacerbations: state of the art. A GA(2)LEN and InterAirways document. Allergy 200726; 62: 457-470
31. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310: 1225-1229
32. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307: 982-986
33. Johnston SL, Pattemore PK, Sanderson G et al. The relationship between upper respiratory infections and hospital admissions for asthma: A time?trend analysis. Am J Respir Crit Care Med 1996; 154: 654-660
34. Grunberg K, Timmers MC, de Klerk EP et al. Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med 1999; 160: 1375-1380
35. Papadopoulos NG, Bates PJ, Bardin PG et al. Rhinoviruses infect the lower airways. J Infect Dis 2000; 181: 1875-1884
36. Corne JM, Marshall C, Smith S et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non?asthmatic individuals: a longitudinal cohort study. Lancet 2002; 359: 831-834
37. Wark PA, Johnston SL, Bucchieri F et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhino virus. J Exp Med 2005; 201: 937-947
38. de Roux A, Marcos MA, Garcia E et al. Viral community-acquired pneu monia in nonimmunocompromised adults. Chest 2004; 125: 1343- 1351
39. Angeles MM, Camps M, Pumarola T et al. The role of viruses in the ae tiology of community-acquired pneumonia in adults. Antivir Ther 2006; 11: 351-359
40. Dowell SF, Anderson LJ, Gary HE Jr et al. Respiratory syncytial virus is an important cause of community?acquired lower respiratory infection among hospitalized adults. J Infect Dis 1996; 174: 456-462
41. Ruiz M, Ewig S, Marcos MA et al. Etiology of community-acquired pneumonia in hospitalized patients: Impact of age, comorbidity and severity. Am J Respir Crit Care Med 1999; 160: 397-405
42. Krech T, Wegmann T, Martin H et al. Etiology of atypical pneumonias. A serological study on 1494 patients. Schweiz Med Wochenschr 1986; 116: 2-7
43. Farr BM, Kaiser DL, Harrison BD et al. Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommit tee. Thorax 1989; 44: 1031-1035
44. Dahmash NS, Chowdhury MN. Re?evaluation of pneumonia requiring admission to an intensive care unit: a prospective study. Thorax 1994; 49: 71-76
45. Bohte R, Furth R van, Broek PJ van den. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 1995; 50: 543-547
46. Socan M, Marinic Fiser N, Kraigher A et al. Microbial aetiology of community-acquired pneumonia in hospitalised patients. Eur J Clin Microbiol Infect Dis 1999; 18: 777-782
47. La SB, Marrie TJ, Auffray JP et al. Mimivirus in pneumonia patients. Emerg Infect Dis 2005; 11: 449-542
48. Woo PCY, Lau SKP, Tsoi Hw et al. Clinical and Molecular Epidemiological Features of Coronavirus HKU1 Associated Community-acquired Pneumonia. The Journal of Infectious Diseases 20 051; 192: 1898- 1907
49. Cebular S, Lee S, Tolaney P et al. Community?acquired pneumonia in immunocompromised patients. Opportunistic infections to consider in differential diagnosis. Postgrad Med 2003; 113: 65-70, 73
50. Duffau P, Moiton MP, Lafon ME et al. A case of severe community-acquired pneumonia and non respiratory illness induced by Influenza A. Med Mal Infect 2006; 36: 473-475
51. Lee N, Rainer TH, Ip M et al. Role of laboratory variables in differentiat ing SARS coronavirus from other causes of community-acquired pneumonia within the first 72h of hospitalization. Eur J Clin Microbiol Infect Dis 2006; 25: 765-772
52. Jennings LC, Anderson TP, Beynon KA et al. Incidence and Characteristics of Viral Community-acquired Pneumonia in Adults. Thorax 2008; 63: 42-48
53. Schlosser B, Rohde G, Borg I et al. Viral and bacterial colonization in intubated patients in the ICU. Proc Am Thorac Soc 2005; 2: A822
54. Daubin C, Parienti JJ, Vincent S et al. Epidemiology and clinical out come of virus-positive respiratory samples in ventilated patients: a prospective cohort study. Crit Care 20 065; 10: R142
55. Allander T, Tammi MT, Eriksson M et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci 2005; 102: 12891-12896
56. Khetsuriani N, Kazerouni NN, Erdman DD et al. Prevalence of viral respiratory tract infections in children with asthma. Journal of Allergy and Clinical Immunology 2007; 119: 314-321
57. Kleines M, Scheithauer S, Rackowitz A et al. High Prevalence of Human Bocavirus Detected in Young Children with Severe Acute Lower Respiratory Tract Disease by Use of a Standard PCR Protocol and a Novel Real-Time PCR Protocol. J Clin Microbiol 2007; 45: 1032-104
58. Kupfer B, Vehreschild J, Cornely O et al. Severe pneumonia and human bocavirus in adult. Emerg Infect Dis 2006; 12: 1614-1616
59. Allander T, Jartti T, Gupta S et al. Human bocavirus and acute wheezing in children. Clin Infect Dis 2007; 44: 904-910
60. Chung JY, Han TH, Kim SW et al. Detection of viruses identified recently in children with acute wheezing. J Med Virol 2007; 79: 1238-1243
61. Fry AM, Lu X, Chittaganpitch M et al. Human bocavirus: a novel parvo-virus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J Infect Dis 2007; 195: 1038-1045
62. Gendrel D, Guedj R, Pons-Catalano C et al. Human bocavirus in children with acute asthma. Clin Infect Dis 2007; 45: 404-405
63. Kim YJ, Boeckh M, Englund JA. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med 2007; 28: 222- 242
64. Lee JI, Chung JY, Han TH et al. Detection of human bocavirus in children hospitalized because of acute gastroenteritis. J Infect Dis 2007; 196: 994-997
65. Lau SK, Yip CC, Que TL et al. Clinical and molecular epidemiology of human bocavirus in respiratory and fecal samples from children in Hong Kong. J Infect Dis 2007; 196: 986-993
66. Vicente D, Cilla G, Montes M et al. Human bocavirus, a respiratory and enteric virus. Emerg Infect Dis 2007; 13: 636-637
67. Bastien N, Brandt K, Dust K et al. Human Bocavirus infection, Canada. Emerg Infect Dis 2006; 12: 848-850
68. Kaplan NM, Dove W, Bu-Zeid AF et al. Human bocavirus infection among children, Jordan. Emerg Infect Dis 2006; 12: 1418-1420
69. Neske F, Blessing K, Tollmann F et al. Real-time PCR for diagnosis of human bocavirus infections and phylogenetic analysis. J Clin Microbiol 2007; 45: 2116-2122
70. Endo R, Ishiguro N, Kikuta H et al. Seroepidemiology of human bocavirus in Hokkaido prefecture, Japan. J Clin Microbiol 2007; 45: 3218- 3223
71. Allander T, Andreasson K, Gupta S et al. Identification of a third human polyomavirus. J Virol 2007; 81: 4130-4136
72. Bialasiewicz S, Whiley DM, Lambert SB et al. A newly reported human polyomavirus, KI virus, is present in the respiratory tract of Australian children. J Clin Virol 2007; 40: 15-18
73. Gaynor AM, Nissen MD, Whiley DM et al. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 2007; 3: e64
74. Norja P, Ubillos I, Templeton K et al. No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J Clin Virol 2007; 40: 307-311
75. Englund JA. Diagnosis and epidemiology of community- acquired respiratory virus infections in the immunocompromised host. Biol Blood Marrow Transplant 2001; 7: 2S-4S
76. Couch RB, Englund JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 1997; 102: 2-9
77. Barton TD, Blumberg EA. Viral pneumonias other than cytomegalo- virus in transplant recipients. Clin Chest Med 2005; 26: 707-720
78. Duncan AJ, Dummer JS, Paradis IL et al. Cytomegalovirus infection and survival in lung transplant recipients. J Heart Lung Transplant 1991; 10: 638-644
79. Ettinger NA, Bailey TC, Trulock EP et al. Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group. Am Rev Respir Dis 1993; 147: 1017-123
80. Zamora MR, Davis RD, Leonard C. Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations. Transplantation 2005; 80: 157-163
81. Humar A, Paya C, Pescovitz MD et al. Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R-solid organ transplant recipients. Am J Transplant 2004; 4: 644-649
82. Venard V, Carret A, Corsaro D et al. Genotyping of adenoviruses iso? lated in an outbreak in a bone marrow transplant unit shows that diverse strains are involved. J Hosp Infect 2000; 44: 71-74
83. Ison MG. Adenovirus infections in transplant recipients. Clin Infect Dis 20 061; 43: 331-339
84. Runde V, Ross S, Trenschel R et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 2001; 28: 51-57
85. Chakrabarti S, Mautner V, Osman H et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002; 100: 1619-1627
86. Baldwin A, Kingman H, Darville M et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant 2000; 26: 1333-1338
87. Shields AF, Hackman RC, Fife KH et al. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med 1985; 312: 529-533
88. Claas EC, Schilham MW, de Brouwer CS et al. Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J Clin Microbiol 2005; 43: 1738-1744
89. Kaiser L, Aubert JD, Pache JC et al. Chronic rhinoviral infection in lung transplant recipients. Am J Respir Crit Care Med 2006; 174: 1392- 1399
90. Nichols WG, Guthrie KA, Corey L et al. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39: 1300-1306
91. Small TN, Casson A, Malak SF et al. Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 321-327
92. Lee I, Barton TD. Viral respiratory tract infections in transplant patients: epidemiology, recognition and management. Drugs 2007; 67: 1411-1427
93. Kraaij MG van, Elden LJ van, Loon AM van et al. Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture. Clin Infect Dis 2005; 40: 662-669
94. Rohde G. Therapeutic targets in respiratory viral infections. Curr Med Chem 2007; 14: 2776-2782